Phreesia (NYSE:PHR) CFO Sells $97,380.24 in Stock

Key Points

• Phreesia CFO, Balaji Gandhi, sold 4,183 shares at an average price of $23.28, totaling approximately $97,380.24, reducing his ownership by 4.05% to 99,125 shares valued at $2,307,630.
• The company's stock closed at $24.28 on the trading day following the transaction, with an average target price from analysts of $34.08, indicating a potential upside.
• Phreesia reported a revenue of $117.26 million for the last quarter, exceeding analysts' expectations, alongside a positive earnings surprise of $0.08 per share.

Phreesia, Inc. (NYSE:PHR - Get Free Report) CFO Balaji Gandhi sold 4,183 shares of the stock in a transaction that occurred on Tuesday, September 16th. The stock was sold at an average price of $23.28, for a total transaction of $97,380.24. Following the completion of the sale, the chief financial officer directly owned 99,125 shares of the company's stock, valued at $2,307,630. This represents a 4.05% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link.

Balaji Gandhi also recently made the following trade(s):

• On Thursday, July 17th, Balaji Gandhi sold 886 shares of Phreesia stock. The shares were sold at an average price of $26.89, for a total transaction of $23,824.54.

Phreesia Stock Performance

PHR stock traded up $1.00 during midday trading on Thursday, reaching $24.28. The company's stock had a trading volume of 801,987 shares, compared to its average volume of 1,182,744. The stock has a fifty day simple moving average of $27.71 and a two-hundred day simple moving average of $26.40. The company has a debt-to-equity ratio of 0.02, a quick ratio of 2.12 and a current ratio of 2.12. Phreesia, Inc. has a 1 year low of $17.07 and a 1 year high of $32.76.

Phreesia (NYSE:PHR - Get Free Report) last issued its quarterly earnings data on Thursday, September 4th. The company reported $0.01 EPS for the quarter, topping analysts' consensus estimates of ($0.07) by $0.08. The company had revenue of $117.26 million during the quarter, compared to the consensus estimate of $116.39 million. Phreesia had a negative net margin of 5.35% and a negative return on equity of 8.75%. Phreesia's revenue for the quarter was up 14.9% compared to the same quarter last year. During the same quarter in the previous year, the firm posted ($0.03) earnings per share. Phreesia has set its FY 2026 guidance at EPS. As a group, equities research analysts forecast that Phreesia, Inc. will post -1.1 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of analysts have recently commented on PHR shares. Stephens reissued an "overweight" rating and set a $32.00 target price on shares of Phreesia in a research note on Wednesday, September 3rd. Wall Street Zen upgraded shares of Phreesia from a "hold" rating to a "buy" rating in a report on Sunday, June 1st. KeyCorp boosted their target price on shares of Phreesia from $28.00 to $35.00 and gave the stock an "overweight" rating in a research note on Monday, July 14th. Truist Financial lifted their target price on Phreesia from $35.00 to $36.00 and gave the stock a "buy" rating in a research report on Friday, September 5th. Finally, Needham & Company LLC upped their price objective on Phreesia from $29.00 to $35.00 and gave the company a "buy" rating in a research note on Friday, September 5th. One research analyst has rated the stock with a Strong Buy rating and twelve have issued a Buy rating to the stock. According to MarketBeat, the company presently has an average rating of "Buy" and a consensus price target of $34.08.

Institutional Trading of Phreesia

Institutional investors and hedge funds have recently bought and sold shares of the company. Raymond James Financial Inc. lifted its position in Phreesia by 2.7% in the second quarter. Raymond James Financial Inc. now owns 14,049 shares of the company's stock worth $400,000 after purchasing an additional 375 shares during the period. Diversified Trust Co increased its stake in shares of Phreesia by 1.0% in the second quarter. Diversified Trust Co now owns 45,042 shares of the company's stock worth $1,282,000 after acquiring an additional 426 shares during the last quarter. PNC Financial Services Group Inc. raised its holdings in shares of Phreesia by 2.8% during the 2nd quarter. PNC Financial Services Group Inc. now owns 19,983 shares of the company's stock valued at $569,000 after purchasing an additional 540 shares in the last quarter. Arcadia Investment Management Corp MI boosted its position in Phreesia by 0.7% during the first quarter. Arcadia Investment Management Corp MI now owns 92,770 shares of the company's stock worth $2,371,000 after purchasing an additional 615 shares during the period. Finally, Oppenheimer Asset Management Inc. increased its stake in shares of Phreesia by 9.9% in the second quarter. Oppenheimer Asset Management Inc. now owns 8,803 shares of the company's stock worth $251,000 after purchasing an additional 792 shares during the period. Institutional investors and hedge funds own 92.10% of the company's stock.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.